£500 to invest? Here’s how I’d look to make a 1,000% return investing in shares

first_img Andy Ross | Thursday, 18th February, 2021 | More on: RENX £500 to invest? Here’s how I’d look to make a 1,000% return investing in shares See all posts by Andy Ross Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Our 6 ‘Best Buys Now’ Shares Andy Ross owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Enter Your Email Addresscenter_img To turn a modest sum of money like £500 into £5,000 from investing in shares, you need to pick the right investments. It’s possible to achieve a 1,000% return with a tracker or a portfolio of income shares, with patience and good stock picking. However, to increase the odds of ten-bagging, I think small cap stocks is the place to look.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Investing in shares which can grow quickly – and what I’d avoidWhen I talk about smaller shares I’m not talking penny stocks – I’d define it more as those with a market cap between £50m and £250m. I want to avoid the very smallest and therefore riskiest companies. A 50% loss on an investment means a 100% gain is needed just to get back to breakeven. That’s achievable, but difficult to do consistently.It’s better to just try and reduce your odds of making the big loss in the first place. So I invest in smaller caps with a long-term mindset and ask: do I really want to hold a small part of this company?This is about investing in high-quality stocks that happen to have low market capitalisations. Probably because they are small, growing businesses, or they have been previously mismanaged.What’s good about small cap shares? Thre are numerous benefits, but among the most important is greater inefficiency in the market. That’s because institutional investors, like the banks and pension funds, do less research on smaller-cap companies. As a result, there are more opportunities to buy undervalued shares.On top of that, small caps can more easily double in size. It’s easier to grow from being worth £50m to £100m, for example, than it is to go from £50bn to £100bn.Thirdly, smaller companies can generally be more agile and in many cases will have founders retaining significant shareholdings. This often makes them more entrepreneurial.A high-risk/high-reward share I have my eye onThe healthcare artificial intelligence (AI) company RenalytixAI (LSE: RENX) is a share that I think has huge potential. Through its KidneyIntelX platform, it provides in vitro diagnostics focused on optimising clinical management of kidney disease.This is a huge market it’s targeting in the US. There it’s awaiting approval from the Food and Drug Administration (FDA) for its tests. Once approved these will be sold at $950 apiece. Then the company should go from no revenue to very fast growth.If the FDA decision comes back against the company, or there is a delay in getting approvals, I’d expect the share price to fall. So there’s a real risk with this share. Especially as at the moment it has no other revenues.Looking long-term, though, I think AI will make big inroads in the healthcare industry over the next decade. I hope, and expect, that RenalytixAI will be a part of that growth. FREE REPORT: Why this £5 stock could be set to surge Are you on the lookout for UK growth stocks?If so, get this FREE no-strings report now.While it’s available: you’ll discover what we think is a top growth stock for the decade ahead.And the performance of this company really is stunning.In 2019, it returned £150million to shareholders through buybacks and dividends.We believe its financial position is about as solid as anything we’ve seen.Since 2016, annual revenues increased 31%In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259Operating cash flow is up 47%. (Even its operating margins are rising every year!)Quite simply, we believe it’s a fantastic Foolish growth pick.What’s more, it deserves your attention today.So please don’t wait another moment. Get the full details on this £5 stock now – while your report is free. Image source: Getty Images. Simply click below to discover how you can take advantage of this.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *